Brief: Sonnet Biotherapeutics Holdings Inc Announces A Collaboration Agreement With Janssen Biotech - Filing

Sonnet Biotherapeutics Holdings

31/10/2022 12:27

Oct 31 (Reuters) - Sonnet Biotherapeutics Holdings Inc
 SONN.O :
    * SONNET BIOTHERAPEUTICS HOLDINGS INC - ANNOUNCING A
COLLABORATION
AGREEMENT WITH JANSSEN BIOTECH
    * SONNET BIOTHERAPEUTICS  - CO'S THREE PRODUCTS, SON-1010,
SON-1210 AND SON-1410 TO BE EVALUATED IN COMBINATION WITH
JANSSEN S CELL THERAPY ASSETS
    * SONNET BIOTHERAPEUTICS HOLDINGS INC - SUBJECT TO
SUCCESSFUL
RESULTS, SONNET COULD SEEK AN EXPANDED COLLABORATION
    * SONNET BIOTHERAPEUTICS HOLDINGS INC - SONNET SHALL SUPPLY
THREE
COMPOUNDS FOR USE IN HEAD-TO-HEAD STUDIES

Source text for Eikon: [https://bit.ly/3UcZ6zA]
Further company coverage:  SONN.O 
 ((Reuters.Briefs@thomsonreuters.com;;))